20.05.2025

Very strong Sales and Earnings Increase in the first quarter 2025

Donaueschingen, 20/05/2025: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 11% and EBT by approx. 37% in the first three months of 2025. As a result, the continually positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 62,988 to KEUR 70,022 (+11.2%) in the first three months 2025. The international share of total business volume was 40.6% (3M-2024 44.5%) and amounted to KEUR 28,449 compared to KEUR 28,011 (3M-2024).

The consolidated earnings before taxes (EBT) rose very sharply by 36.8% to KEUR 11,899 (3M-2024 KEUR 8,695). The earnings before interest and taxes (EBIT) rose sharp by 34.5% to KEUR 11,259 (3M-2024 KEUR 8,373). The EBITA increased by 31.6% from KEUR 9,898 (3M-2024) to KEUR 13,026. The consolidated surplus rose by 23.1% to KEUR 8,239 (3M-2024 KEUR 6,695). The consolidated earnings before interest, taxes, depreciation and amortisation (EBITDA) developed positively. It improved signifcantly by 23.0% to KEUR 15,934 (3M-2024 KEUR 12,953).

Operating cashflow increased by 33.9% to KEUR 34,199 (3M-2024 KEUR 25,541).

As of 31/03/2025, the company had cash resources at its disposal in the amount of KEUR 144,886 (31/12/2024: KEUR 117,219). Nexus AG had equity capital amounting to KEUR 290,871 as of 31/03/2025 (31/12/2024: KEUR 263,852). Consequently, the equity capital rate is 61.1% (31/12/2024: 64.6%).

Downloads

You might also be interested in

- NEXUS-Gruppe
VERY STRONG REVENUES AND EARNINGS INCREASE IN 2022

Donaueschingen, 07/03/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its revenues by 11.1% and EBIT by 15.2% in the fiscal year 2022. As a result, the continually positive development of revenues and earnings of the last two decades could be continued.
- NEXUS-Gruppe
Strong sales and earnings increase in the first half-year 2023

Donaueschingen, 15 August 2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 12% and EBT by 23% in the first six months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.
- NEXUS-Gruppe
VERY STRONG SALES AND EARNINGS INCREASE IN THE FIRST QUARTER 2023

Donaueschingen, 16/05/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 11% and EBIT by approx. 28% in the first three months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.
- NEXUS-Gruppe
Very strong sales and earnings increase in the third quarter 2023

Donaueschingen, 07/11/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 14% and EBT by approx. 33% in the first nine months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.
- NEXUS-Gruppe
VERY STRONG REVENUES AND EARNINGS INCREASE IN 2023

Donaueschingen, 05/03/2024: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its revenues by 15.5% and EBT by 21% in the fiscal year 2023. As a result, the continually positive development of revenues and earnings of the last two decades could be continued.